2026 Production Plan Set for a record 10 Metric Tons of Recombinant Spider Silk Cocoon Per Month 

ANN ARBOR, Mich., February 9, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing.

Kraig's technology is built upon the use of modified silkworms to produce recombinant spider silk. Within the next 30 days, the Company will begin large-scale deployment of its stockpile of proprietary spider silk silkworm eggs. Production plans are now fully in place. Release is scheduled to begin the first week of March. Spider silk output is expected to ramp rapidly, with Kraig Labs hitting full output of 10 metric tons of recombinant spider silk cocoon per month by May.

At full capacity, this level of sustained spider silk output represents a scale that has never been seen before. No company has ever operated anywhere close to this volume of naturally spun recombinant spider silk. This production program is a true game changer for the commercialization of spider silk and firmly positions Kraig Labs as the world leader in this field. 

Kraig Labs is committed to sustaining this operational capacity with plans for adding even more production capacity later in 2026. 

Kraig Labs has engineered and refined proprietary production strains designed for durability, consistency, and high yields of recombinant spider silk. These production lines have been advanced through repeated rearing cycles to ensure stability, resilience, and dependable performance at an industrial scale.

In parallel, the Company has made substantial investments in facilities, workforce expansion, and vertically integrated production infrastructure. Together, these elements form a manufacturing platform built for scale and execution. Kraig Labs has unlocked an entirely new standard for spider silk production.

"This is the most exciting and ambitious program for spider silk production the world has ever seen. Achieving multi-ton level output unlocks key markets and sales channels," said Kim Thompson, Founder and CEO of Kraig Labs. "We are setting standards for spider silk production that were previously thought unreachable. This is a defining moment for our Company and spider silk technology. We believe this will be a transformative moment for Kraig Labs and the commercialization of spider silk."

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company's investor updates at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is build on a scientifically engineered silkworm which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com